Bridget E. Bunner

Array ( [id] => 5374686 [patent_doc_number] => 20090312247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'NATRIURETIC PEPTIDE RELATED FRAGMENT IN CARDIOVASCULAR DISEASE' [patent_app_type] => utility [patent_app_number] => 12/096581 [patent_app_country] => US [patent_app_date] => 2006-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 34028 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312247.pdf [firstpage_image] =>[orig_patent_app_number] => 12096581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056903 [patent_doc_number] => 20070059825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'CYTOKINE ZALPHA11 LIGAND ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 11/551127 [patent_app_country] => US [patent_app_date] => 2006-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 70820 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059825.pdf [firstpage_image] =>[orig_patent_app_number] => 11551127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7751669 [patent_doc_number] => 08110552 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-07 [patent_title] => 'Antagonists against interaction of PF4 and RANTES' [patent_app_type] => utility [patent_app_number] => 12/090010 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7913 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/110/08110552.pdf [firstpage_image] =>[orig_patent_app_number] => 12090010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 221145 [patent_doc_number] => 07608691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'Antibodies against IL-16 antagonist peptides' [patent_app_type] => utility [patent_app_number] => 11/544055 [patent_app_country] => US [patent_app_date] => 2006-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9059 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608691.pdf [firstpage_image] =>[orig_patent_app_number] => 11544055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5034142 [patent_doc_number] => 20070098681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Apo-2 ligand/trail variants and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/541821 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 29464 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20070098681.pdf [firstpage_image] =>[orig_patent_app_number] => 11541821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5563654 [patent_doc_number] => 20090136506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Conserved Membrane Activator of Calcineurin (CMAC), a Novel Therapeutic Protein and Target' [patent_app_type] => utility [patent_app_number] => 12/089005 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 26849 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136506.pdf [firstpage_image] =>[orig_patent_app_number] => 12089005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5062546 [patent_doc_number] => 20070224185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same' [patent_app_type] => utility [patent_app_number] => 11/537235 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 550 [patent_figures_cnt] => 550 [patent_no_of_words] => 59859 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224185.pdf [firstpage_image] =>[orig_patent_app_number] => 11537235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5069545 [patent_doc_number] => 20070190647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Isolation and use of solid tumor stem cells' [patent_app_type] => utility [patent_app_number] => 11/529869 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 39270 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190647.pdf [firstpage_image] =>[orig_patent_app_number] => 11529869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 239288 [patent_doc_number] => 07592003 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-22 [patent_title] => 'Regulation of toll-like receptors on stem cells' [patent_app_type] => utility [patent_app_number] => 11/537200 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 26834 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592003.pdf [firstpage_image] =>[orig_patent_app_number] => 11537200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355468 [patent_doc_number] => 20090186812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Apo-2 ligand' [patent_app_type] => utility [patent_app_number] => 11/528951 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 27176 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186812.pdf [firstpage_image] =>[orig_patent_app_number] => 11528951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5171795 [patent_doc_number] => 20070072227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Gamma secretase notch biomarkers' [patent_app_type] => utility [patent_app_number] => 11/526995 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8698 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072227.pdf [firstpage_image] =>[orig_patent_app_number] => 11526995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102149 [patent_doc_number] => 07723019 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Organic cation transporter preferentially expressed in hematopoietic cells and leukemias and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/521487 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 10043 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723019.pdf [firstpage_image] =>[orig_patent_app_number] => 11521487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5171283 [patent_doc_number] => 20070071714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Stem cell factor' [patent_app_type] => utility [patent_app_number] => 11/517619 [patent_app_country] => US [patent_app_date] => 2006-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 120 [patent_figures_cnt] => 120 [patent_no_of_words] => 52083 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20070071714.pdf [firstpage_image] =>[orig_patent_app_number] => 11517619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391190 [patent_doc_number] => 20090208503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'IMMUNOTHERAPEUTIC TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/065413 [patent_app_country] => US [patent_app_date] => 2006-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12671 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208503.pdf [firstpage_image] =>[orig_patent_app_number] => 12065413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097437 [patent_doc_number] => 20110003746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Protein variants' [patent_app_type] => utility [patent_app_number] => 11/512046 [patent_app_country] => US [patent_app_date] => 2006-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23690 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003746.pdf [firstpage_image] =>[orig_patent_app_number] => 11512046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5171804 [patent_doc_number] => 20070072236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors' [patent_app_type] => utility [patent_app_number] => 11/508069 [patent_app_country] => US [patent_app_date] => 2006-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 18064 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072236.pdf [firstpage_image] =>[orig_patent_app_number] => 11508069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016216 [patent_doc_number] => 20070259425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Stem cell derived factors for treating pathologic conditions' [patent_app_type] => utility [patent_app_number] => 11/508010 [patent_app_country] => US [patent_app_date] => 2006-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16533 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259425.pdf [firstpage_image] =>[orig_patent_app_number] => 11508010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5182950 [patent_doc_number] => 20070054297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Mammalian relaxin receptors' [patent_app_type] => utility [patent_app_number] => 11/497641 [patent_app_country] => US [patent_app_date] => 2006-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15638 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054297.pdf [firstpage_image] =>[orig_patent_app_number] => 11497641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 299560 [patent_doc_number] => 07537758 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Antibodies against a peptide epitope of apolipoprotein B' [patent_app_type] => utility [patent_app_number] => 11/485549 [patent_app_country] => US [patent_app_date] => 2006-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11451 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/537/07537758.pdf [firstpage_image] =>[orig_patent_app_number] => 11485549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6449669 [patent_doc_number] => 20100145006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'SUPRAVALENT COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/917991 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 23645 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20100145006.pdf [firstpage_image] =>[orig_patent_app_number] => 11917991 [rel_patent_id] =>[rel_patent_doc_number] =>)